|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0008838,
umls-concept:C0030705,
umls-concept:C0078257,
umls-concept:C0205420,
umls-concept:C0246415,
umls-concept:C0441771,
umls-concept:C0817096,
umls-concept:C1511484,
umls-concept:C1519810,
umls-concept:C1522449
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2007-4-5
|
|
pubmed:abstractText |
To evaluate the feasibility and efficacy of docetaxel consolidation therapy after concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
810-5
|
|
pubmed:dateRevised |
2008-5-6
|
|
pubmed:meshHeading |
pubmed-meshheading:17409964-Adult,
pubmed-meshheading:17409964-Aged,
pubmed-meshheading:17409964-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17409964-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17409964-Cisplatin,
pubmed-meshheading:17409964-Combined Modality Therapy,
pubmed-meshheading:17409964-Disease-Free Survival,
pubmed-meshheading:17409964-Female,
pubmed-meshheading:17409964-Humans,
pubmed-meshheading:17409964-Lung Neoplasms,
pubmed-meshheading:17409964-Male,
pubmed-meshheading:17409964-Middle Aged,
pubmed-meshheading:17409964-Radiation Injuries,
pubmed-meshheading:17409964-Survival Rate,
pubmed-meshheading:17409964-Taxoids,
pubmed-meshheading:17409964-Vinblastine
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Docetaxel consolidation therapy following cisplatin, vinorelbine, and concurrent thoracic radiotherapy in patients with unresectable stage III non-small cell lung cancer.
|
|
pubmed:affiliation |
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. isekine@ncc.go.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
